Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parkinson's disease: Individual placebo responses are predicted by baseline expression of a striato-limbic network.

Research square·2026
Same author

Automated measurement of left ventricular ejection time via contactless suprasternal notch laser vibrometry.

Scientific reports·2026
Same author

Correction: Glycoprotein non-metastatic melanoma protein B is a biomarker of inflammation in individuals with Gaucher disease: relationship to clinico-pathological subtypes.

Orphanet journal of rare diseases·2025
Same author

Glycoprotein non-metastatic melanoma protein B is a biomarker of inflammation in individuals with Gaucher disease: relationship to clinico-pathological subtypes.

Orphanet journal of rare diseases·2025
Same author

Clinical Outcome Assessments in Parkinson's Disease: A Scoping Review of Current Rating Scales and Future Needs.

Movement disorders clinical practice·2025
Same author

Temporal visual processing deficits in post concussion syndrome.

Scientific reports·2025

Related Experiment Video

Updated: Jun 17, 2026

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

Microsaccade Dynamics During Visual Fixation as Markers for Parkinson's Disease: A Machine Learning Approach.

Yiting Wang1, Panagiota Tsitsi2,3, Ioanna Markaki2,3

  • 1Department of Clinical Neuroscience, Eye and Vision, Karolinska Institutet, Stockholm, Sweden.

Translational Vision Science & Technology
|June 16, 2026
PubMed
Summary

Microsaccades, or tiny eye movements, can distinguish Parkinson's disease (PD) patients from healthy individuals. This research highlights their potential as early biomarkers for motor dysfunction in PD.

More Related Videos

Using Saccadometry with Deep Brain Stimulation to Study Normal and Pathological Brain Function
05:44

Using Saccadometry with Deep Brain Stimulation to Study Normal and Pathological Brain Function

Published on: July 14, 2016

Eye Tracking Young Children with Autism
09:03

Eye Tracking Young Children with Autism

Published on: March 27, 2012

Related Experiment Videos

Last Updated: Jun 17, 2026

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

Using Saccadometry with Deep Brain Stimulation to Study Normal and Pathological Brain Function
05:44

Using Saccadometry with Deep Brain Stimulation to Study Normal and Pathological Brain Function

Published on: July 14, 2016

Eye Tracking Young Children with Autism
09:03

Eye Tracking Young Children with Autism

Published on: March 27, 2012

Area of Science:

  • Oculomotor research
  • Neuroscience
  • Biomarker discovery

Background:

  • Microsaccades are small, rapid eye movements crucial in visual and oculomotor research.
  • Their utility as biomarkers for neurodegenerative movement disorders like Parkinson's disease (PD) is largely unexplored.

Purpose of the Study:

  • To investigate if microsaccade characteristics can differentiate individuals with PD from healthy controls (HCs).
  • To assess the potential of microsaccades as early diagnostic markers for Parkinson's disease.

Main Methods:

  • Eye movements were recorded from 50 individuals with early-to-moderate PD and 43 HCs during a visual fixation task.
  • Machine learning classifiers were trained and evaluated using microsaccade features to predict PD status.
  • Analysis focused on microsaccade frequency, amplitude, and directional bias.

Main Results:

  • Microsaccades in the PD group were more frequent, had larger amplitudes, and showed a stronger horizontal bias compared to HCs.
  • Machine learning models significantly outperformed chance, with a polynomial Support Vector Machine (SVM) achieving 77.4% accuracy.
  • Balanced sensitivity (76.1%) and specificity (78.9%) were achieved, with improved performance at the subject level by managing low-confidence predictions.

Conclusions:

  • Microsaccades contain discriminative information that can distinguish individuals with PD from HCs.
  • These findings support the potential of microsaccades as early indicators of motor dysfunction in Parkinson's disease.
  • This study provides a foundation for developing clinical prediction models based on oculomotor behavior.